CD Antigen Cancer Therapy Drugs Market Revenue Projections and Demand to 2033
Cellular immunotherapy has fundamentally changed treatment outlooks for patients with advanced hematologic malignancies who have exhausted standard therapy options. By genetically engineering a patient's autologous T cells to express synthetic receptors, researchers can direct the immune system to recognize and destroy cancer cells expressing distinct CD surface markers. The rapidly expanding...
0 Σχόλια 0 Μοιράστηκε 2 Views 0 Προεπισκόπηση
Comunidad EDUCA https://comunidadeduca.com